feed,title,long_url,short_url
Investors,"BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out?",https://www.investors.com/news/technology/bridgebio-stock-bayer-acoramidis-deal-vyndaqel/,https://da.gd/FO3OmO
